pro 16, 2021 by Philips
Reading time: 1-2 minutes
Ostial and bifurcation lesions represent nearly 40% of complex PCI’s.1
Sign up to receive news and updates from Philips
1. Kedhi E, Joesoef KS, McFadden E, Wassing J, van Mieghem C, Goedhart D, Smits PC. Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trial. Lancet. 2010 Jan 16;375(9710):201-9.
2. Patel et al. Impact of intravascular ultrasound on the long-term clinical outcomes in the treatment of coronary ostial lesions. Catheter Cardiovasc Interv 2013 June 1. In press doi: 10.1002/ccd.25034.)
3. Iakovou I, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug eluting stents. JAMA 2005;293:2126:2130.
4. Kim, S, Kim Y, et al, Long-Term Outcomes of Intravascular Ultrasound-Guided Stenting in Coronary Bifurcation Lesions, Am J Cardiol 2010;106:612– 618.
5. Mooney M, Teirstein P, Moses J, et al. Final results from the U.S. multi-center trial of the AngioSculpt Scoring Balloon Catheter for the treatment of complex coronary artery lesions. Am J Cardiol. 2006;98 (suppl 8):121M.
6. Weisz G, Metzger DC, Liberman HA, O’Shaughnessy CD, Douglas JS, Turco MA, Mehran R, Gershony G, Leon MB, Moses JW. A provisional strategy for treating true bifurcation lesions employing a scoring balloon for the side branch: Final Results of the AGILITY Trial. Catheterization and Cardiovascular Interventions 2013;82(3):352-359.
You are about to visit a Philips global content page
ContinueOve internet stranice namijenjene su isključivo osoblju koje se koristi medicinskim proizvodima u obavljanju svoje djelatnosti, uključujući zdravstvene radnike, osoblje koje postupa u ime zdravstvenih institucija i/ili osoblje koje se profesionalno bavi trgovinom medicinskim proizvodima.
Spadate li u kategoriju osoba koje udovoljavaju gornjim kriterijima?